Esquire Names PC Advocate Michael Milken As One of 75 Most Influential People of the Century

/, Articles of Interest/Esquire Names PC Advocate Michael Milken As One of 75 Most Influential People of the Century

I just wanted to share this good news.  For those who don’t know him, Michael Milken is a financier and longtime PC patient, as well as a major fundraiser for the prostate cancer.  He founded the Prostate Cancer Foundation, (pcf.org), which is the richest PC charity in the world.

A more recent project of Milken’s is Fastercures.org, which I have written about here.  The goal of this nonprofit organization is to come up with creative ways to fund research for new drugs so that they don’t take 15 years to come to market!

MM did commit some white-collar crime, but he has truly redeemed himself, in my opinion. 

If you live near the Hollywood Hills, check out the event.

Here’s the story (from Esquire release):

—————————————————————————————————————-

Esquire’s 75th Anniversary Issue Features Features FasterCures Chairman Mike Milken as one of the 75 Most Influential People of the 21st Century

 

September 9, 2008 (Washington, DC) – Esquire’s 75th anniversary issue released Sunday debuts the FasterCures public service announcement, Fifteen Years: That’s how long it takes to develop new medical treatments. The ad highlights FasterCures’ core principle of saving lives by saving time. Also in this issue, Esquire names Mike Milken, Chairman of the Milken Institute and Chairman of FasterCures, as one of the 75 Most Influential People of the 21st Century citing his decades-long commitment to improving the medical research infrastructure to accelerate the development of cures.

Since 2003, Esquire has hosted a series of Esquire House events on behalf of nonprofit organizations. On November 12, Esquire House Hollywood Hills will host FasterCures, one of six organizations to hold events at this remarkable venue this year.

By | 2017-10-19T10:57:06+00:00 September 10th, 2008|Advocacy, Articles of Interest|0 Comments

About the Author:

Leave A Comment